Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Isaacs

Showing results (411-420 of 499) with videos related to

Pageof 50
Sort By:
Cancer & Metabolism|September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
The American Journal of Pathology|November 7, 2001
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cellsX Lin, M Tascilar, W H Lee, et al.
Cell & Bioscience|January 15, 2019
Dynamics expression of <i>DmFKBP12/Calstabin</i> during embryonic early development of <i>Drosophila melanogaster</i>Rui Feng, Xin Zhou, Wei Zhang, et al.
The Prostate|March 10, 2018
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancerYishuo Wu, Hongjie Yu, S Lilly Zheng, et al.
American Journal of Human Genetics|July 10, 2001
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23J Xu, S L Zheng, G A Hawkins, et al.
The Prostate|July 26, 2018
Germline mutations in PPFIBP2 are associated with lethal prostate cancerYishuo Wu, Hongjie Yu, Siqun Lilly Zheng, et al.
Mutation Research|July 23, 2003
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association studySiqun L Zheng, Josyf C Mychaleckyj, Gregory A Hawkins, et al.
The Prostate|August 22, 2006
A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS studyS Lilly Zheng, Wennuan Liu, Fredrik Wiklund, et al.
The Prostate|May 23, 2025
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN GuidelinesJianfeng Xu, Jim Lu, Marta Gielzak, et al.
Journal of the National Cancer Institute|March 11, 2026
Divergent effects of PLA2G7 on prostate cancer biochemical recurrence in european American and african American menChanning J Paller, Shuanzeng Wei, Megan Schumacher, et al.
Pageof 50

Showing results (411-420 of 499) with videos related to

Sort By:
Pageof 50
Cancer & Metabolism|September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
The American Journal of Pathology|November 7, 2001
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cellsX Lin, M Tascilar, W H Lee, et al.
Cell & Bioscience|January 15, 2019
Dynamics expression of <i>DmFKBP12/Calstabin</i> during embryonic early development of <i>Drosophila melanogaster</i>Rui Feng, Xin Zhou, Wei Zhang, et al.
The Prostate|March 10, 2018
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancerYishuo Wu, Hongjie Yu, S Lilly Zheng, et al.
American Journal of Human Genetics|July 10, 2001
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23J Xu, S L Zheng, G A Hawkins, et al.
The Prostate|July 26, 2018
Germline mutations in PPFIBP2 are associated with lethal prostate cancerYishuo Wu, Hongjie Yu, Siqun Lilly Zheng, et al.
Mutation Research|July 23, 2003
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association studySiqun L Zheng, Josyf C Mychaleckyj, Gregory A Hawkins, et al.
The Prostate|August 22, 2006
A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS studyS Lilly Zheng, Wennuan Liu, Fredrik Wiklund, et al.
The Prostate|May 23, 2025
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN GuidelinesJianfeng Xu, Jim Lu, Marta Gielzak, et al.
Journal of the National Cancer Institute|March 11, 2026
Divergent effects of PLA2G7 on prostate cancer biochemical recurrence in european American and african American menChanning J Paller, Shuanzeng Wei, Megan Schumacher, et al.
Pageof 50